Dopamine and ADHD: The Mechanism, Plain Language

You have probably read that ADHD is a “dopamine deficiency”. This is a useful simplification. It is also incomplete and partly misleading. The actual story is more interesting.

What dopamine actually does

Dopamine is one of several neurotransmitters in the brain. In simple terms, it is involved in:

• Signalling that something is rewarding or worth attending to.
• Motivation to act.
• Movement control.
• Mood regulation.
• Working memory and attention switching.

Dopamine is not the “pleasure chemical” of pop neuroscience. It is closer to the “this matters, do it” chemical. It tells the brain to allocate resources toward something.

What is different in ADHD

The current best research picture, drawn from imaging studies, post-mortem studies, and pharmacological response data, is something like this:

• ADHD brains have differences in how dopamine and noradrenaline are produced, released, and reabsorbed in specific frontal-striatal circuits.
• One specific finding: dopamine transporter density (the protein that pulls dopamine back into the cell after it has done its signalling) is elevated in some ADHD brain regions. This means dopamine signal gets cut short.
• Another finding: receptor sensitivity is sometimes different, so even when dopamine is present, the downstream cells respond less to it.
• The result is that the “this matters, do it” signal does not arrive cleanly for tasks that other brains would find motivating.

What stimulant medications actually do

Methylphenidate and amphetamine-class medications work by increasing the amount of dopamine and noradrenaline available in the synapse. They do this differently:

• Methylphenidate primarily blocks the dopamine transporter (and noradrenaline transporter), so dopamine that is released stays around longer to do its signalling work.
• Amphetamines also increase release of dopamine from the cell, and inhibit reuptake.

The net effect for the patient: the brain’s “this matters, do it” signal works closer to the way it works in non-ADHD brains. Boring tasks become more accessible. Task initiation gets easier. Sustained attention works better.

This is not “drugging the brain to a different state”. For most well-titrated ADHD patients, medication makes the brain function closer to baseline rather than into a different state. Patients often report feeling “more like myself” rather than feeling drugged.

What atomoxetine does differently

Atomoxetine is the principal non-stimulant ADHD medication used in India. It works on noradrenaline reuptake specifically, with downstream effects on dopamine in the prefrontal cortex but not in the striatum (the brain region most associated with stimulant misuse and addiction).

This is why atomoxetine has different abuse liability and a different regulatory category (Schedule H rather than Schedule X under Indian regulation), and also why its effect profile is different. It is generally less powerful than stimulants for the average patient but has its own role.

The limits of the dopamine story

Three honest caveats about the dopamine story that the popular framing often misses:

It is not just dopamine

Noradrenaline matters at least as much. Other neurotransmitters and circuit-level differences are involved. Calling ADHD “low dopamine” is convenient but incomplete.

It is a network problem, not a single-region problem

The functional brain differences in ADHD show up across multiple regions and the connectivity between them. The prefrontal cortex, the striatum, the cerebellum, and several connecting tracts all show measurable differences in some studies. There is no single “ADHD brain region” any more than there is a single “ADHD gene”.

Brain differences are statistical, not categorical

If you took two hundred ADHD brains and two hundred non-ADHD brains, you could measure differences on average. But there is overlap. You cannot reliably diagnose ADHD from a brain scan because the diagnostic criteria are clinical, and the brain markers, while real, are not specific or sensitive enough for individual diagnosis.

This is why functional MRI ADHD diagnosis services that you see marketed online are not, on the available evidence, doing what they claim.

What this means for treatment decisions

The mechanism explanation has practical implications:

• Medications targeted at the underlying neurochemistry work because they target the underlying neurochemistry. They are not “just helping you focus.”
• Behavioural strategies work in part by providing external structure that reduces the cognitive load on impaired circuits.
• Combination approaches (medication plus behavioural strategies) often work better than either alone, because they address the mechanism from two directions.

Frequently asked questions

Can I increase my dopamine naturally?

Some interventions (exercise, sleep, sunlight, certain foods) modestly affect dopamine and have general health benefits. None are reliable substitutes for clinical treatment when ADHD is moderate or severe. The “dopamine menu” lifestyle content online is mostly entertainment.

Will medication damage my brain?

The clinical research on long-term ADHD medication use, including in pediatric populations, has not found evidence of brain damage. Specific concerns (height velocity in children, cardiovascular effects in adults) are real, manageable, and managed through clinical monitoring.

Why do stimulants make me feel calmer instead of stimulated?

This is a common observation in ADHD patients and is consistent with the “regulating dysregulated dopamine” framing. Therapeutic-dose stimulants in ADHD brains tend to normalise rather than over-stimulate. People without ADHD often experience the same medications as classically stimulating.

Sources

• Volkow ND et al. on dopamine transporter studies in ADHD.
• Faraone SV et al. (2021). World Federation of ADHD International Consensus Statement.
• Russell A. Barkley, Attention-Deficit Hyperactivity Disorder.
• Sharma A, Couture J. (2014). A review of methylphenidate and atomoxetine pharmacology.